An amendment to this paper has been published and can be accessed via the original article.
Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
Putignani, LorenzaFunding Acquisition
;
2022-01-01
Abstract
An amendment to this paper has been published and can be accessed via the original article.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
